[ad_1] Valsartan is off patent and is used as a component of other generic drugs, but not all drugs containing the ingredient are involved, according to the FDA. The US recall includes …
Read More »FDA joins recall of 22 common cardiac drugs
Medication Recall Against Hypertension Due to Contamination by a Potential Carcinogen – National
[ad_1] Drug manufacturers are recalling several drugs containing the valsartan ingredient, according to a Health Canada press release on Tuesday. The recalled medications are used to treat patients with high blood pressure …
Read More »Recall of a common medicine against the heart in 22 countries for a carcinogenic chemical
[ad_1] Valsatran drugs are often administered to control high blood pressure and prevent heart failure. The drug is currently being recalled in 22 countries after the discovery of traces of a carcinogenic …
Read More »Recall of a common medicine against the heart in 22 countries for a possible link with cancer
[ad_1] Valsartan is sold without a patent and is used as a component of other generic drugs. Novartis, the company that originally developed the drug, said Sandoz valsartan and valsartan / HCT …
Read More »Health Product Regulatory Authority Statement on Drug Recall
[ad_1] The following is an edited version of the statement issued by the HPRA on Thursday: The Health Products Regulatory Authority (HPRA) states today that it is proceeding with a Preventive reminder …
Read More »